| Name | Title | Contact Details |
|---|
At 4Catalyzer we are transforming 21st century medicine by solving today’s most challenging problems – across life science tools, medical devices and therapeutics. We aspire to create significant societal impact and are motivated by the idea that our products will change the lives of people we love. We seek the talent of truly gifted, self-starting and driven individuals to help advance this mission. We provide a stimulating environment, surrounded by brilliant, highly committed individuals who are given both the autonomy and project ownership to solve difficult problems and be the first to publish. Each 4Catalyzer company endeavors to develop technologies that enable unprecedented looks at nature thereby affording the opportunity to do prize-winning science and publish in top-tier journals like Science and Nature. Our advisors have pioneered their fields. Our technology base includes truly novel Devices, Deep Learning and the Cloud. We understand that success requires surrounding yourself with the right people, being at the right place at the right time, and having the resources to get the job done.
Conor Medsystems, Inc. develops controlled vascular drug delivery technologies. It has initially focused on the development of drug-eluting stents to treat coronary artery disease. Its stents have been specifically designed for vascular drug delivery, in
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."
Medical Device Depot is a Ellicott City, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.